CEF12 is an EBV-derived peptide containing residues 399-408 from NA3B, supporting T-cell epitope mapping and viral-sequence motif analysis. Its structure enables studies of β-turn formation and residue accessibility. Researchers assess conformational states to identify conserved antigenic determinants. The peptide aids comparative viral-epitope investigations.
CAT No: C14012
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.